Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
01/13/2017 01/16/2017 01/17/2017 01/18/2017 01/19/2017 Date
103.6(c) 101.95(c) 102.2(c) 103.3(c) 102.8 Last
402 853 267 174 381 001 503 055 445 923 Volume
+2.22% -1.59% +0.25% +1.08% -0.48% Change
More quotes
Financials (€)
Sales 2016 15 044 M
EBIT 2016 3 509 M
Net income 2016 1 706 M
Debt 2016 11 023 M
Yield 2016 1,19%
Sales 2017 15 577 M
EBIT 2017 3 514 M
Net income 2017 1 882 M
Debt 2017 9 019 M
Yield 2017 1,29%
P/E ratio 2016 25,92
P/E ratio 2017 22,97
EV / Sales2016 1,62x
EV / Sales2017 1,44x
Capitalization 13 351 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.It operates through the following segments: Healthcare, Life Science, and Performance Materials.The Healthcare segment comprises of the businesses that were reported separately as the Merck Serono and Consumer Health... 
Sector
Pharmaceuticals
Calendar
03/09Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
07:38p MERCK KGAA : Darmstadt, Germany, Licenses Four Oncology Research and Development..
01/18 MERCK : Launches First Commercial Screening Service to Predict Multiple Sources ..
01/18 MERCK : MilliporeSigma Kicks Off Year-Long 'Curiosity Cube' Tour
01/18 MERCK : And Palantir Technologies Inc Agree On Cancer Data Analysis Pact
01/17 MERCK : Moves Executives Between Businesses and Group Functions
01/17 MERCK : Opens Production Facility Exclusively for Meglumine in Spain
01/16 MERCK : Drives Business Opportunities in the U.S. to Foster Innovation Across al..
01/13 MERCK : Introduces New Calibration Kit for In Vitro Diagnostic Use
01/12 MERCK : MilliporeSigma Kicks Off Year-Long ‘Curiosity Cube™’ T..
01/12 MERCK : and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration
More news
Sector news : Specialty & Advanced Pharmaceuticals
09:03pDJRival to EpiPen Allergy Treatment to Return to Market
04:33p Davos CEOs 'go local' on supply chain in Trump era
11:15a GSK grabs Astra executive to replace pharma head
10:40aDJGLAXOSMITHKLINE : Global Pharmaceuticals President Abbas Hussain to Leave -- Upd..
08:48aDJBusiness Watch -- WSJ
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2016Towards the breakout of a major resistance level
2014Prices move higher as positive news are released
More Strategies
Latest Tweets
06:28pMerck KGaA given €109.00 PT by Commerzbank AG. neutral rating.  
05:31pMerck CEO sees Keytruda in pole position in cancer race
13
05:15pMerck & Co. Release: MSD For Mothers Commits $10 Million And Business Exp.. 
03:45pShares of Merck slide 0.6% at $60.63 to lead Dow laggards in early trade #new.. 
01/18Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers .. 
More tweets
Qtime:164
News from SeekingAlpha
01/18 Astra's Mystic Mystery And Other Surprises In Store
01/12 Vertex And German Merck Find Their Perfect Fit
01/12 JPMorgan Day Three Roundup - Trump Reminds The Sector Who's In Charge
01/11 Vertex to collaborate with Germany's Merck in oncology
01/10 German Merck Unveils Its Secret Weapon
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 108 €
Spread / Average Target 4,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA3.08%14 207
ABBVIE INC-1.53%100 204
KYOWA HAKKO KIRIN CO L..-2.22%7 882
JAZZ PHARMACEUTICALS P..17.96%7 703
MALLINCKRODT PLC-8.75%4 926
ZHANGZHOU PIENTZEHUANG..-1.16%3 988
More Results